This is a knowledge base for any and all things related to EGFR-positive NSCLC. Where possible and relevant, all information published on this website should include references. References should preferentially be actual embedded copies of papers and presentations, rather than links which can rapidly become out-of-date, or have restricted access.
  0 votes
  1 answers
  0 comments
  142 views

[WORK IN PROGRESS - DESCRIPTIONS HERE ARE INTENDED TO BE BRIEF. MORE IN-DEPTH DESCRIPTIONS CAN BE ON SEPARATE PAGES, AND LINKED TO FROM HERE.]
  0 votes
  1 answers
  0 comments
  1224 views

  0 votes
  0 answers
  0 comments
  87 views

  0 votes
  0 answers
  0 comments
  89 views

[In progress - answer should describe both anti-CTLA4 and anti-PD-1/PD-L1 inhibitors.]
  0 votes
  0 answers
  0 comments
  66 views

  0 votes
  1 answers
  0 comments
  82 views

  0 votes
  1 answers
  0 comments
  102 views

(7 / 7)

Recent Activity

More


Base Managers
Robert Hanlon
Member (20)
Lars Soraas
Member (20)
Aaron Andersen
Member (20)
Marcia Horn
Director, the Exon 20 Group (20)
Mark Sinclair-McGarvie
Member (405)

Quandora Stats
1
Knowledge Bases
7
questions
4
answers
0
active tags
1
active users